CC
EGRX

Corton Capital’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Corton Capital’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-11,917
Closed -$62.3K – 686
2023
Q4 		$62.3K Buy
+11,917
New +$62.3K 0.02% 558